The global cosmetic surgery market was valued at $67,289.1 million in 2021, and is projected to reach $201,025.5 million by 2031, registering a CAGR of 11.6% from 2022 to 2031. Cosmetic surgery is a type of plastic surgery that aims to improve a person’s appearance. It is the unique discipline of medicine focused on enhancing appearance through surgical and medical techniques. Cosmetic surgery can be performed on any part of the face or body. It is a voluntary choice made by a patient to have cosmetic surgery. It includes body contouring, breast enhancement, facial contouring, facial rejuvenation, skin rejuvenation, eyelid surgery, liposuction, rhinoplasty, and facelift. The non-surgical procedure includes botulinum toxin, soft tissue fillers, laser skin resurfacing, microdermabrasion, intense pulsed light, chemical peel, and laser skin resurfacing.
The cosmetic surgery market is driven by increase in number of cosmetic procedures such as body contouring, breast enhancement, facial contouring, increase in demand for aesthetic treatment, rise in awareness regarding skin health, and surge in expenditure on human healthcare services. Moreover, increase in number of key players to launch various cosmetic surgery products boosts growth of the market. Increase in number of licensed medical spas. Rise in self-awareness among young population regarding aesthetic appearance is anticipated to propel growth of the market. According to a report by the American society of plastic surgeons (ASPS), in 2020, it was reported that around 16 million cosmetic procedures are conducted, globally. As per the same source, it was also reported that consumers spent approximately $20 billion on cosmetic surgery procedures globally for total consumers. Breast augmentation surgery remains leading aesthetic surgical procedure in the U.S. According to the aesthetic society, over 250,000 primary breast augmentation procedures were performed in the U.S. in 2020. According to the Galderma, one of the aesthetic product manufacturing companies, increase in number of new products for cosmetic surgery also boosts the market. For instance, in January 2021, Candela Syneron, a healthcare equipment manufacturing company, announced the launch of the frax pro system. It is a smarter version of frax dual-depth skin resurfacing device.
However, side effects associated with cosmetic procedures and high cost of surgical cosmetic procedures are anticipated to hinder the market growth during the forecast period. Side effects such as complication related to anesthesia, infection, edema, abnormal scaring, numbness, or nerve damage at the surgical site hinder growth of the market. Development of products with advanced technologies for cosmetic procedures boost demand for cosmetic surgery and provide growth opportunities for the cosmetic surgery market. For instance, in February 2022, Galderma, a pharmaceutical company, announced the launch of alastin skincare reform and repair complex with trihex technology. It is designed to assist in recovery from surgical body procedure.
The global cosmetic surgery market is segmented on the basis of procedure, gender, age group, provider and region. The procedure segment is further bifurcated into breast augmentation, eyelid surgery, liposuction, rhinoplasty and others. On the basis of geneder market is segmented into female and male. On the basis of age group market is segmented into 13 to 29, 30 to 54 and 55 and others. On the basis of provider market is segmented into ambulatory surgical facilities, hospitals & clinics, office & cosmetic surgical center. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global cosmetic surgery market include AbbVie Inc., Bausch Health Companies Inc., Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma, and Teoxane Laboratories
The cosmetic surgery market is driven by increase in number of cosmetic procedures such as body contouring, breast enhancement, facial contouring, increase in demand for aesthetic treatment, rise in awareness regarding skin health, and surge in expenditure on human healthcare services. Moreover, increase in number of key players to launch various cosmetic surgery products boosts growth of the market. Increase in number of licensed medical spas. Rise in self-awareness among young population regarding aesthetic appearance is anticipated to propel growth of the market. According to a report by the American society of plastic surgeons (ASPS), in 2020, it was reported that around 16 million cosmetic procedures are conducted, globally. As per the same source, it was also reported that consumers spent approximately $20 billion on cosmetic surgery procedures globally for total consumers. Breast augmentation surgery remains leading aesthetic surgical procedure in the U.S. According to the aesthetic society, over 250,000 primary breast augmentation procedures were performed in the U.S. in 2020. According to the Galderma, one of the aesthetic product manufacturing companies, increase in number of new products for cosmetic surgery also boosts the market. For instance, in January 2021, Candela Syneron, a healthcare equipment manufacturing company, announced the launch of the frax pro system. It is a smarter version of frax dual-depth skin resurfacing device.
However, side effects associated with cosmetic procedures and high cost of surgical cosmetic procedures are anticipated to hinder the market growth during the forecast period. Side effects such as complication related to anesthesia, infection, edema, abnormal scaring, numbness, or nerve damage at the surgical site hinder growth of the market. Development of products with advanced technologies for cosmetic procedures boost demand for cosmetic surgery and provide growth opportunities for the cosmetic surgery market. For instance, in February 2022, Galderma, a pharmaceutical company, announced the launch of alastin skincare reform and repair complex with trihex technology. It is designed to assist in recovery from surgical body procedure.
The global cosmetic surgery market is segmented on the basis of procedure, gender, age group, provider and region. The procedure segment is further bifurcated into breast augmentation, eyelid surgery, liposuction, rhinoplasty and others. On the basis of geneder market is segmented into female and male. On the basis of age group market is segmented into 13 to 29, 30 to 54 and 55 and others. On the basis of provider market is segmented into ambulatory surgical facilities, hospitals & clinics, office & cosmetic surgical center. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global cosmetic surgery market include AbbVie Inc., Bausch Health Companies Inc., Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma, and Teoxane Laboratories
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cosmetic surgery market analysis from 2021 to 2031 to identify the prevailingcosmetic surgery market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cosmetic surgery market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cosmetic surgery market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Gender
- Female
- Male
By Age Group
- 13 to 29
- 30 to 54
- 55 and above
By Procedure
- Breast augmentation
- Eyelid surgery
- Liposuction
- Rhinoplasty
- Others
By End User
- Ambulatory surgical facility
- Hospital and clinic
- Office and cosmetic surgical center
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- India
- Australia
- Rest of Asia-Pacific
- China
- Japan
- LAMEA
- Brazil
- Saudi Arabia
- Colombia
- Rest of LAMEA
Key Market Players
- Abbvie Inc
- Bausch Health Companies Inc.
- Candela Syneron
- cynosure inc
- Galderma SA
- Merz Pharma GmbH and Co. KGaA
- Sientra Inc
- Sinclair Pharmaceuticals Limited
- Teoxane Laboratories
- Johnson and Johnson
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: COSMETIC SURGERY MARKET, BY PROCEDURE
CHAPTER 5: COSMETIC SURGERY MARKET, BY GENDER
CHAPTER 6: COSMETIC SURGERY MARKET, BY AGE GROUP
CHAPTER 7: COSMETIC SURGERY MARKET, BY END USER
CHAPTER 8: COSMETIC SURGERY MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Cosmetic Surgery Market,' the cosmetic surgery market size was valued at $67.3 billion in 2021, and is estimated to reach $201.0 billion by 2031, growing at a CAGR of 11.6% from 2022 to 2031. Cosmetic surgery is where a person chooses to have an operation or invasive medical procedure to change their physical appearance for aesthetic rather than medical reason. Cosmetic surgery means redesigning body’s contour and shape, smoothing wrinkles, or eliminating balding areas. There are various types of cosmetic surgery procedures that women and men can choose to create an image that makes them feel more confident and comfortable with their appearance. Top cosmetic surgeries are breast augmentation, liposuction, nose reshaping, eyelid surgery, tummy tuck, and facelift. Some non-surgical procedures such as botulinum toxin that temporarily reduces or eliminates facial fine lines and wrinkles. Laser skin resurfacing can reduce facial wrinkles, scars, and blemishes. Microdermabrasion treatments use a minimally abrasive instrument to gently sand skin, removing thicker, uneven outer layer, and has many benefits. According to report share by American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) in February 2022, total number of surgical and non-surgical procedures is up to 1.4 million in year 2021, and have increased by 40% than 2020.Factors that drive cosmetic surgery market trends includes increase in number of cosmetic procedures. According to the report share by the American academy of facial plastic and reconstructive surgery, (AAFPRS), it was reported that the number of surgical and non-surgical procedures have been increasing day by day. According to a report by Statista, published in January 2022, the most common cosmetic surgical procedure was breast augmentation. Approximately, 1.6 million augmentation procedures were performed worldwide in 2020. The second most common cosmetic surgical procedure is liposuction and approximately 1.5 million liposuction procedures were performed worldwide in 2020. According to a report by Statista, published in 2021, botulinum toxin is the highest non-surgical procedure performed worldwide. Approximately 2.6 million botulinum toxin procedures were performed in 2020 across the globe. Increase in number of key players to launch various cosmetic surgery products and rise in number approval for the cosmetic surgery products propel the cosmetic surgery market growth. Galderma is a dermatology and pharmaceutical company, which received approval for two products. In May 2020, it received food & drug administration (FDA) approval for restylane kysse, a new hyaluronic acid (ha) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth. In February 2021, it received food & drug administration (FDA) approval for restylane defyne for augmentation and correction of mild to moderate chin retrusion for adults over the age of 21. Increase in number of licensed medical spas. The reason behind increasing number of medical spas is attributed to increase in number of non-invasive procedures such as cryolipolysis, laser lipolysis, liposuction, and tummy tuck. These procedures are highly popular among women due to increased levels of self-consciousness and a desire to be beautiful. Increase in skin damage and changes in lifestyle are the major factors that lead to rise in number of medical spas.
The cosmetic surgery market size is segmented procedure, gender, age group, provider, and region.
On the basis of procedure, the market is classified into breast augmentation, eyelid surgery, liposuction, rhinoplasty, and others. The surgical segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in number of breast augmentation procedures and increase in number of approvals for cosmetic surgeries in breast implant.
On the basis of gender, it is classified into male and female. The female segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in demand for aesthetic procedures, rapidly growing emphasis on personal aesthetics among females, and increase in number of female populations conducting cosmetic surgery.
On the basis of age group, the market is classified into 13 to29, 30 to 54, and 55 and others. The 30 to 54 segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in demand for liposuction and rise in number of cosmetic procedures in population of age group 30-54.
On the basis of provider, the market is classified into ambulatory surgical facilities, hospital and clinics, office & cosmetic surgical center. The hospitals & clinics segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in number of cosmetic surgeries and rise in number of hospitals and clinics to conduct various surgical procedures.
North America accounted for a majority of the global cosmetic surgery market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in number of breast augmentation procedures, increase in number of approvals for cosmetic surgery products, presence of cosmetic surgery industry, and advancements in healthcare, medical devices, and aesthetic sector in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of liposuctions, rise in awareness among young population regarding aesthetics, growth in health care expenditures, and rise in adoption of aesthetic products.
Key findings of the Study
- By surgical procedure, the breast augmentation segment was the highest contributor to the market in 2021.
- By gender, the female segment was the highest contributor to the market in 2021.
- By age group, the 30 to54 segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
- By provider, the hospitals & clinics segment was the highest contributor to the market in 2021.
- By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Abbvie Inc
- Bausch Health Companies Inc.
- Candela Syneron
- cynosure inc
- Galderma SA
- Merz Pharma GmbH and Co. KGaA
- Sientra Inc
- Sinclair Pharmaceuticals Limited
- Teoxane Laboratories
- Johnson and Johnson
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 270 |
| Published | May 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 67289.1 million |
| Forecasted Market Value ( USD | $ 201025.5 million |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
